Our products
The key strategy of our long-term development:
portfolio expansion of our own pharmaceutical products manufactured in the countries of Eurasian Economic Union
From the idea to the release of finished products
Our team of professionals, together with the key medical opinion leaders, RND experts and top industry players involved in registration and pharmaceutical contract manufacturing, implements tasks from an idea to a finished product
01
Comprehensive search for promising molecules - potential candidates for reproduction and local manufacturing
02
Pharmaceutical development of Finished Dosage Form (FDF), finding suitable contract manufacturing site(s) and technology transfer
03
State registration (regulatory approval) of developed product according to the requirements of Eurasian Economic Union
04
Commercial production of Finished Dosage Form in cooperation with leading Russian and foreign Contract manufacturers fully compliant with GMP requirements and Russian industry standards
The basis of our product portfolio - generics of the highest quality
RINPHARM owns several products that have proven to be high quality, competitive and effective medicines with a steady consumer demand. Knowing firsthand the patients' problems, we strive to increase the efficasy of their treatment.

Our goal is to provide patients with high-quality, effective and safe pharmaceutical products at affordable prices.
Medical products
Rutram<sup>®</sup>
Rutram®
Combined analgesic (Tramadol + Paracetamol)
More info
Colimistin<sup>®</sup>
Colimistin®
Cyclic polypeptide antibiotic belonging to the polymyxin group
More info
Infira<sup>®</sup>
Infira®
Antiepileptic drug
More info
Talopsa<sup>®</sup>
Talopsa®
Antiepileptic drug
More info
USE OF COOKIES. We use cookies. This allows us to improve your future experience on our website.